March 6, 2021 8:39 AM
Latest:
  • US Unemployment Rate Falls to 6.2%, Pushing 10-Year Treasuries to New Highs
  • ARK Invest: Sailing Into The Wind
  • Tim Seymour: Are Institutions Looking To Invest In US Cannabis Stocks? – The Daily Dive
  • India Lures Tesla With Offer of Cheaper Manufacturing Costs Than China
  • Trulieve: Analysts Expect Beat On Company Full Year Guidance
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Cannabis
      • Pure Extracts
      • Tinley Beverage Co
    • Mining
      • AUX Resources
      • Freeman Gold
      • Newlox Gold Ventures
      • Noram Ventures
      • Riverside Resources
      • SKRR Exploration Inc.
      • Spruce Ridge Resources
    • Technology
      • CloudMD
      • Datametrex AI Limited
      • MustGrow Biologics
      • PowerBand Solutions
      • Revive Therapeutics
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Revive Therapeutics

Briefing Psychedelics 

Growing Medical Acceptance of Psychedelics – The Daily Dive feat Derek Welsh of Revive Therapeutics

December 4, 2020 1:00 PMDecember 4, 2020 12:45 PM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

For our final episode of The Daily Dive this week, host Cassandra Leah is joined by that of Derek Welsh

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics, Pharmather Partner On Psilocybin Cancer Research

November 18, 2020 7:30 AMNovember 18, 2020 7:30 AM Jay Lutz 0 Comments Pharmather, Revive Therapeutics

Revive Therapeutics (CSE: RVV) and Pharmather Inc (CSE: PHRM) this morning jointly announced a research collaboration between the two firms.

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Completes Psilocybin Oral Thin Film Strip Product

November 11, 2020 9:35 AMNovember 11, 2020 9:36 AM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) has completed its oral thin film strip product for psilocybin after several months of prototyping. The

Share
Tweet
Share
Read more
Briefing News Technology 

Revive Expects To Complete Phase 3 Interim Analysis In December On Bucillamine In Treatment of COVID-19

October 26, 2020 10:54 AMOctober 26, 2020 10:54 AM Jay Lutz 0 Comments Coronavirus, Revive Therapeutics

Revive Therapeutics (CSE: RVV) provided an update on the status of its ongoing phase three clinical trials for the evaluation

Share
Tweet
Share
Read more
Briefing Psychedelics 

Havn Life to Supply Revive Therapeutics With Psychedelic Compounds

October 20, 2020 10:16 AMOctober 20, 2020 10:16 AM Small Cap Steve 0 Comments HAVN Life Sciences, Revive Therapeutics

This morning Revive Therapeutics (CSE: RVV) announced they have signed a supply agreement with Havn Life Sciences Inc. (CSE : HAVN) to source

Share
Tweet
Share
Read more
Biotech Briefing 

Revive Selects Clinical Sites for FDA Phase 3 Clinical Trials

September 29, 2020 9:45 AMSeptember 29, 2020 10:37 AM Small Cap Steve 0 Comments COVID-19, Revive Therapeutics

This morning Revive Therapeutics Ltd (CSE: RVV, OTV: RVVTF), announced they have selected five clinical sites in Florida, Texas and

Share
Tweet
Share
Read more
Briefing News Technology 

Revive Sees Expanded Access Protocol Approved For Compassionate Use Of Bucillamine

September 16, 2020 8:23 AMSeptember 16, 2020 8:23 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that it has received approval from the Independent Institutional Review Board (IRB) for

Share
Tweet
Share
Read more
Briefing Psychedelics Technology 

Revive Therapeutics To Conduct Phase 1 Clinical Trials For Psilocybin

September 2, 2020 8:43 AMSeptember 2, 2020 8:45 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) is driving forward with its psilocybin studies. The company announced this morning that it has entered

Share
Tweet
Share
Read more
Briefing Technology 

Revive Receives Approval From Independent Review Board For Phase Three Study

August 31, 2020 8:56 AMAugust 31, 2020 8:56 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) is one step closure to commencing its phase three clinical trials for the use of Bucillamine

Share
Tweet
Share
Read more
Biotech Briefing Psychedelics 

Revive Submits for IRB Approval; Expects to Enroll Patients in September

August 26, 2020 10:07 AMAugust 26, 2020 10:07 AM Small Cap Steve 0 Comments COVID-19, Revive Therapeutics

This morning Revive Therapeutics (CSE: RVV, USA: RVVTF) announced they have submitted a clinical trial protocol to their independent Institutional

Share
Tweet
Share
Read more
  • ← Previous
  • Next →

Briefings

US Unemployment Rate Falls to 6.2%, Pushing 10-Year Treasuries to New Highs
Bonds Briefing Macro 

US Unemployment Rate Falls to 6.2%, Pushing 10-Year Treasuries to New Highs

March 5, 2021 4:01 PM Hermina Paull 0

The highly anticipated payrolls report was forecast to show a significant improvement in the US labour market, leaving stocks stuck

ARK Invest: Sailing Into The Wind
Briefing Full Analysis Macro 

ARK Invest: Sailing Into The Wind

March 5, 2021 2:51 PM Braden Maccke 0
Tim Seymour: Are Institutions Looking To Invest In US Cannabis Stocks? – The Daily Dive
Briefing Cannabis Video Series 

Tim Seymour: Are Institutions Looking To Invest In US Cannabis Stocks? – The Daily Dive

March 5, 2021 1:30 PM Jay Lutz 0
India Lures Tesla With Offer of Cheaper Manufacturing Costs Than China
Automotive Briefing 

India Lures Tesla With Offer of Cheaper Manufacturing Costs Than China

March 5, 2021 11:47 AM Hermina Paull 1
Trulieve: Analysts Expect Beat On Company Full Year Guidance
Briefing Cannabis 

Trulieve: Analysts Expect Beat On Company Full Year Guidance

March 5, 2021 10:37 AM Justin Young 0
Medipharm Labs Closes $33.4 Million Bought Deal Financing
Briefing Cannabis 

Medipharm Labs Closes $33.4 Million Bought Deal Financing

March 5, 2021 9:12 AM Jay Lutz 0
Tru Precious Metals Closes $3.5 Million Subscription Receipt Offering
Briefing Resources 

Tru Precious Metals Closes $3.5 Million Subscription Receipt Offering

March 5, 2021 8:57 AM Jay Lutz 0

Spotlight Series

Tim Seymour: Are Institutions Looking To Invest In US Cannabis Stocks? – The Daily Dive
Briefing Cannabis Video Series 

Tim Seymour: Are Institutions Looking To Invest In US Cannabis Stocks? – The Daily Dive

March 5, 2021 1:30 PM Jay Lutz 0

For the final episode of The Daily Dive for the trading week, we sit down with Tim Seymour, founder and

News

DigiMax Provides Progress Update For CryptoDivine
Blockchain Briefing News 

DigiMax Provides Progress Update For CryptoDivine

March 5, 2021 8:38 AM Jay Lutz 0

DigiMax Global Solutions (CSE: DIGI) this morning provided an update for its Crypto Price Trend Indicator App. The firm reported

Pure Extracts Applies For Dealers License With Health Canada
Briefing News Psychedelics 

Pure Extracts Applies For Dealers License With Health Canada

March 4, 2021 7:13 AM Jay Lutz 0
Relay Medical Acquires Cybersecurity Firm Cybeats Technology
Briefing News Technology 

Relay Medical Acquires Cybersecurity Firm Cybeats Technology

March 3, 2021 4:49 PM Jay Lutz 0
Exploits Discovery Announces 4,500 Metre Drill Program For Dog Bay Property
Briefing News Resources 

Exploits Discovery Announces 4,500 Metre Drill Program For Dog Bay Property

March 3, 2021 9:24 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Need some freelance work done? We’re experienced in many forms of writing, including press releases. Shoot us an email & let’s chat!

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Psychedelics
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2021 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.